Impact of mean platelet volume on combined safety endpoint and vascular and bleeding complications following percutaneous transfemoral transcatheter aortic valve implantation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Magri, Caroline J ^a   Chieffo, Alaide ^a   Durante, Alessandro ^a   Latib, Azeem ^a   Montorfano, Matteo ^a   Maisano, Francesco ^a   Cioni, Michela ^a   Agricola, Eustachio ^a   Covello, Remo Daniel ^a   Gerli, Chiara ^a   Franco, Annalisa ^a   Spagnolo, Pietro ^a   Alfieri, Ottavio ^a   Colombo, Antonio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; HEMOGLOBIN; PROTON PUMP INHIBITOR; WARFARIN;

ACUTE KIDNEY FAILURE; AGED; AORTA DISSECTION; AORTA VALVE PROSTHESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLEEDING; CORONARY ARTERY OBSTRUCTION; ERYTHROCYTE COUNT; FEMALE; HEART INFARCTION; HEART TAMPONADE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; PATIENT SAFETY; PERCUTANEOUS AORTIC VALVE; PERCUTANEOUS TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RETROSPECTIVE STUDY; SHOCK; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; VERY ELDERLY; AORTA VALVE; PATHOLOGY; PROSTHESES AND ORTHOSES; TREATMENT OUTCOME;

AGED; AORTIC VALVE; FEMALE; HEMORRHAGE; HUMANS; MALE; MEAN PLATELET VOLUME; MYOCARDIAL INFARCTION; PROSTHESES AND IMPLANTS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84896082990     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/645265     Document Type: Article

References (44)

1. Piazza N., Grube E., Gerckens U., den Heijer P., Linke A., Luha O., Ramondo A., Ussia G., Wenaweser P., Windecker S., Laborde J.-C., de Jaegere P., Serruys P. W., Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008 4 2 242 249 2-s2.0-55849132881
2. Zahn R., Gerckens U., Grube E., Linke A., Sievert H., Eggebrecht H., Hambrecht R., Sack S., Hauptmann K. E., Richardt G., Figulla H.-R., Senges J., Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. European Heart Journal 2011 32 2 198 204 2-s2.0-78651506594 10.1093/eurheartj/ehq339
3. Eltchaninoff H., Prat A., Gilard M., Leguerrier A., Blanchard D., Fournial G., Iung B., Donzeau-Gouge P., Tribouilloy C., Debrux J.-L., Pavie A., Gueret P., Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. European Heart Journal 2011 32 2 191 197 2-s2.0-78651469380 10.1093/eurheartj/ehq261
4. Bosmans J. M., Kefer J., de Bruyne B., Herijgers P., Dubois C., Legrand V., Verheye S., Rodrigus I., Procedural, 30-day and one year outcome following corevalve or edwards transcatheter aortic valve implantation: results of the belgian national registry. Interactive Cardiovascular and Thoracic Surgery 2011 12 5 762 767 2-s2.0-79956206865 10.1510/icvts.2010.253773
5. Tamburino C., Capodanno D., Ramondo A., Petronio A. S., Ettori F., Santoro G., Klugmann S., Bedogni F., Maisano F., Marzocchi A., Poli A., Antoniucci D., Napodano M., de Carlo M., Fiorina C., Ussia G. P., Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011 123 3 299 308 2-s2.0-79251565276 10.1161/CIRCULATIONAHA.110.946533
6. Rodés-Cabau J., Webb J. G., Cheung A., Ye J., Dumont E., Feindel C. M., Osten M., Natarajan M. K., Velianou J. L., Martucci G., DeVarennes B., Chisholm R., Peterson M. D., Lichtenstein S. V., Nietlispach F., Doyle D., DeLarochellière R., Teoh K., Chu V., Dancea A., Lachapelle K., Cheema A., Latter D., Horlick E., Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. acute and late outcomes of the multicenter canadian experience. Journal of the American College of Cardiology 2010 55 11 1080 1090 2-s2.0-77649212932 10.1016/j.jacc.2009.12.014
7. Leon M. B., Smith C. R., Mack M., Miller D. C., Moses J. W., Svensson L. G., Tuzcu E. M., Webb J. G., Fontana G. P., Makkar R. R., Brown D. L., Block P. C., Guyton R. A., Pichard A. D., Bavaria J. E., Herrmann H. C., Douglas P. S., Petersen J. L., Akin J. J., Anderson W. N., Wang D., Pocock S., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. The New England Journal of Medicine 2010 363 17 1597 1607 2-s2.0-77958594295 10.1056/NEJMoa1008232
8. Smith C. R., Leon M. B., Mack M. J., Miller D. C., Moses J. W., Svensson L. G., Tuzcu E. M., Webb J. G., Fontana G. P., Makkar R. R., Williams M., Dewey T., Kapadia S., Babaliaros V., Thourani V. H., Corso P., Pichard A. D., Bavaria J. E., Herrmann H. C., Akin J. J., Anderson W. N., Wang D., Pocock S. J., Transcatheter versus surgical aortic-valve replacement in high-risk patients. The New England Journal of Medicine 2011 364 23 2187 2198 2-s2.0-79958204372 10.1056/NEJMoa1103510
9. Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M. B., Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002 106 24 3006 3008 2-s2.0-0037058854 10.1161/01.CIR.0000047200.36165.B8 (Pubitemid 35440280)
10. Kodali S. K., Williams M. R., Smith C. R., Svensson L. G., Webb J. G., Makkar R. R., Fontana G. P., Dewey T. M., Thourani V. H., Pichard A. D., Fischbein M., Szeto W. Y., Lim S., Greason K. L., Teirstein P. S., Malaisrie S. C., Douglas P. S., Hahn R. T., Whisenant B., Zajarias A., Wang D., Akin J. J., Anderson W. N., Leon M. B., Two-year outcomes after transcatheter or surgical aortic-valve replacement. The New England Journal of Medicine 2012 366 18 1686 1695 2-s2.0-84860466759 10.1056/NEJMoa1200384
11. Kappetein A. P., Head S. J., Généreux P., Piazza N., van Mieghem N. M., Blackstone E. H., Brott T. G., Cohen D. J., Cutlip D. E., van Es G. A., Hahn R. T., Kirtane A. J., Krucoff M. W., Kodali S., Mack M. J., Mehran R., Rodés-CabauJ, Vranckx P., Webb J. G., Windecker S., Serruys P. W., Leon M. B., Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. European Heart Journal 2012 33 19 2403 2418
12. Gurvitch R., Toggweiler S., Willson A. B., Wijesinghe N., Cheung A., Wood D. A., Ye J., Webb J. G., Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 2011 7 1 41 48 2-s2.0-80051751721 10.4244/EIJV7I1A10
13. Stähli B. E., Bünzli R., Grünenfelder J., Bühler I., Felix C., Bettex D., Biaggi P., Tanner F. C., Nguyen-Kim D. L., Plass A., Ge H., Falk V., Lüscher T. F., Corti R., Maier W., Altwegg L. A., Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC). Journal of Invasive Cardiology 2011 23 8 307 312 2-s2.0-80051984494
14. Toggweiler S., Gurvitch R., Leipsic J., Wood D. A., Willson A. B., Binder R. K., Cheung A., Ye J., Webb J. G., Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. Journal of the American College of Cardiology 2012 59 2 113 118 2-s2.0-84855403379 10.1016/j.jacc.2011. 08.069
15. Nuis R.-J., van Mieghem N. M., van Der Boon R. M., van Geuns R.-J., Schultz C. J., Oei F. B., Galema T. W., Raap G. B., Koudstaal P. J., Geleijnse M. L., Kappetein A. P., Serruys P. W., de Jaegere P. P., Effect of experience on results of transcatheter aortic valve implantation using a medtronic CoreValve system. American Journal of Cardiology 2011 107 12 1824 1829 2-s2.0-79957940876 10.1016/j.amjcard.2011.02.315
16. Hayashida K., Lefvre T., Chevalier B., Hovasse T., Romano M., Garot P., Mylotte D., Uribe J., Farge A., Donzeau-Gouge P., Bouvier E., Cormier B., Morice M.-C., Transfemoral aortic valve implantation: new criteria to predict vascular complications. JACC 2011 4 8 851 858 2-s2.0-84860389030 10.1016/j.jcin.2011.03. 019
17. Généreux P., Head S. J., van Mieghem N. M., Kodali S., Kirtane A. J., Xu K., Smith C., Serruys P. W., Kappetein A. P., Leon M. B., Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions. a weighted meta-analysis of 3.519 patients from 16 studies. Journal of the American College of Cardiology 2012 59 2317 2326 2-s2.0-84859454610 10.1016/j.jacc.2012.02.022
18. Frojmovic M. M., Milton J. G., Human platelet size, shape, and related functions in health and disease. Physiological Reviews 1982 62 1 185 261 2-s2.0-0020008173
19. Bath P. M. W., Butterworth R. J., Platelet size: measurement, physiology and vascular disease. Blood Coagulation and Fibrinolysis 1996 7 2 157 161 2-s2.0-0029888976 (Pubitemid 26167943)
20. Thompson C. B., Jakubowski J. A., Quinn P. G., Platelet size as a determinant of platelet function. Journal of Laboratory and Clinical Medicine 1983 101 2 205 213 2-s2.0-0020694253 (Pubitemid 13152003)
21. Martin J. F., Trowbridge E. A., Salmon G., Plumb J., The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thrombosis Research 1983 32 5 443 460 2-s2.0-0021034220 (Pubitemid 14243216)
22. Khatri P. J., Webb J. G., Rodés-Cabau J., Fremes S. E., Ruel M., Lau K., Guo H., Wijeysundera H. C., Ko D. T., Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Annals of Internal Medicine 2013 158 1 35 46
23. Toggweiler S., Webb J. G., Challenges in transcatheter aortic valve implantation. Swiss Medical Weekly 2012 142 w13735
24. van Der Loo B., Martin J. F., A role for changes in platelet production in the cause of acute coronary syndromes. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 672 679 2-s2.0-0032974078 (Pubitemid 29135170)
25. Bath P., Algert C., Chapman N., Neal B., Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004 35 3 622 626 2-s2.0-1442274814 10.1161/01.STR.0000116105.26237.EC (Pubitemid 38280830)
26. Hendra T. J., Oswald G. A., Yudkin J. S., Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Research and Clinical Practice 1988 5 1 63 69 2-s2.0-0023948716
27. Thompson C. B., Jakubowski J. A., The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1988 72 1 1 8 2-s2.0-0023789399
28. White J. G., Platelet pathology in carriers of the X-linked GATA-1 macrothrombocytopenia. Platelets 2007 18 8 620 627 2-s2.0-36549090533 10.1080/09537100701655384 (Pubitemid 350179045)
29. Giles H., Smith R. E. A., Martin J. F., Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. European Journal of Clinical Investigation 1994 24 1 69 72 2-s2.0-0028290004 (Pubitemid 24204957)
30. Kamath S., Blann A. D., Lip G. Y. H., Platelet activation: assessment and quantification. European Heart Journal 2001 22 17 1561 1571 2-s2.0-0034863137 10.1053/euhj.2000.2515 (Pubitemid 32801301)
31. Karpatkin S., Khan Q., Freedman M., Heterogeneity of platelet function. Correlation with platelet volume. American Journal of Medicine 1978 64 4 542 546 2-s2.0-0017796624 (Pubitemid 8322900)
32. Jakubowski J. A., Adler B., Thompson C. B., Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. Journal of Laboratory and Clinical Medicine 1985 105 2 271 276 2-s2.0-0021886547 (Pubitemid 15036949)
33. Vizioli L., Muscari S., Muscari A., The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. International Journal of Clinical Practice 2009 63 10 1509 1515 2-s2.0-70349260634 10.1111/j.1742-1241.2009.02070.x
34. Makay B., Türkyilmaz Z., Duman M., Ünsal E., Mean platelet volume in Henoch-Schönleinpurpura: relationship to gastrointestinal bleeding. Clinical Rheumatology 2009 28 1225 1228
35. Vincentelli A., Susen S., Le Tourneau T., Six I., Fabre O., Juthier F., Bauters A., Decoene C., Goudemand J., Prat A., Jude B., Acquired von Willebrand syndrome in aortic stenosis. The New England Journal of Medicine 2003 349 4 343 349 2-s2.0-0038793349 10.1056/NEJMoa022831 (Pubitemid 36886240)
36. Berndt M. C., Shen Y., Dopheide S. M., Gardiner E. E., Andrews R. K., The vascular biology of the glycoprotein Ib-IX-V complex. Thrombosis and Haemostasis 2001 86 1 178 188 2-s2.0-0034923236 (Pubitemid 32663951)
37. Takahashi N., Tanabe K., Yoshitomi H., Adachi T., Ito S., Sugamori T., Endo A., Ishibashi Y., Oda T., Impairment of platelet retention rate in patients with severe aortic valve stenosis. Journal of Cardiology 2013 62 3 171 175
38. Bernelli C., Chieffo A., Montorfano M., Maisano F., Latib A., Carlino M., Figini F., Giannini F., Buchanan G. L., Covello R. D., Gerli C., Annalisa F., Agricola E., La Canna G., Alfieri O., Colombo A., Bleeding events after transcatheter aortic valve implantation: usefulness of baseline activated clotting time in guiding the antithrombotic regimen during transcatheter aortic valve implantation procedures. Journal of the American College of Cardiology 2013 61 10 supplement 12 10.1016/S0735-1097(13)61905-1
39. van Mieghem N. M., Tchetche D., Chieffo A., Dumonteil N., Messika-Zeitoun D., van der Boon R. M., Vahdat O., Buchanan G. L., Marcheix B., Himbert D., Serruys P. W., Fajadet J., Colombo A., Carrié D., Vahanian A., de Jaegere P. P., Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Journal of the American College of Cardiology 2012 110 9 1361 1367
40. Buchanan G. L., Chieffo A., Montorfano M., Maisano F., Latib A., Godino C., Cioni M., Gullace M. A., Franco A., Gerli C., Alfieri O., Colombo A., The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN and Medtronic CoreValve ReValving System devices: the Milan registry. EuroIntervention 2011 7 5 556 563 2-s2.0-80055113552 10.4244/EIJV7I5A91
41. Mussardo M., Latib A., Chieffo A., Godino C., Ielasi A., Cioni M., Takagi K., Davidavicius G., Montorfano M., Maisano F., Carlino M., Franco A., Covello R. D., Spagnolo P., Grimaldi A., Alfieri O., Colombo A., Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve. JACC 2011 4 7 743 750 2-s2.0-79960617727 10.1016/j.jcin.2011.05.004
42. Hayashida K., Lefvre T., Chevalier B., Hovasse T., Romano M., Garot P., Mylotte D., Uribe J., Farge A., Donzeau-Gouge P., Bouvier E., Cormier B., Morice M.-C., Transfemoral aortic valve implantation: new criteria to predict vascular complications. JACC 2011 4 8 851 858 2-s2.0-84860389030 10.1016/j.jcin.2011.03. 019
43. Sinning J. M., Horack M., Grube E., Gerckens U., Erbel R., Eggebrecht H., Zahn R., Linke A., Sievert H., Figulla H. R., Kuck K. H., Hauptmann K. E., Hoffmann E., Hambrecht R., Richardt G., Sack S., Senges J., Nickenig G., Werner N., The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry. American Heart Journal 2012 164 1 102 10.e1
44. Wenaweser P., Windecker S., Anatomical suitability for transcatheter aortic valve implantation with complementary roles for 2 rivals. JACC 2010 3 8 867 869 2-s2.0-78651293118 10.1016/j.jcin.2010.07.002